These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12501180)

  • 1. Crystal structures of two potent nonamidine inhibitors bound to factor Xa.
    Adler M; Kochanny MJ; Ye B; Rumennik G; Light DR; Biancalana S; Whitlow M
    Biochemistry; 2002 Dec; 41(52):15514-23. PubMed ID: 12501180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, characterization, and the crystal structure of the inhibitor ZK-807834 (CI-1031) complexed with factor Xa.
    Adler M; Davey DD; Phillips GB; Kim SH; Jancarik J; Rumennik G; Light DR; Whitlow M
    Biochemistry; 2000 Oct; 39(41):12534-42. PubMed ID: 11027132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors.
    Chou YL; Davey DD; Eagen KA; Griedel BD; Karanjawala R; Phillips GB; Sacchi KL; Shaw KJ; Wu SC; Lentz D; Liang AM; Trinh L; Morrissey MM; Kochanny MJ
    Bioorg Med Chem Lett; 2003 Feb; 13(3):507-11. PubMed ID: 12565961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activity.
    Wiley MR; Weir LC; Briggs S; Bryan NA; Buben J; Campbell C; Chirgadze NY; Conrad RC; Craft TJ; Ficorilli JV; Franciskovich JB; Froelich LL; Gifford-Moore DS; Goodson T; Herron DK; Klimkowski VJ; Kurz KD; Kyle JA; Masters JJ; Ratz AM; Milot G; Shuman RT; Smith T; Smith GF; Tebbe AL; Tinsley JM
    J Med Chem; 2000 Mar; 43(5):883-99. PubMed ID: 10715155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and characterization of a potent and selective non-amidine inhibitor of human factor Xa.
    Liang AM; Light DR; Kochanny M; Rumennik G; Trinh L; Lentz D; Post J; Morser J; Snider M
    Biochem Pharmacol; 2003 May; 65(9):1407-18. PubMed ID: 12732352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and activity of a novel series of factor Xa inhibitors: optimization of arylamidine groups.
    Phillips G; Guilford WJ; Buckman BO; Davey DD; Eagen KA; Koovakkat S; Liang A; McCarrick M; Mohan R; Ng HP; Pinkerton M; Subramanyam B; Ho E; Trinh L; Whitlow M; Wu S; Xu W; Morrissey MM
    J Med Chem; 2002 Jun; 45(12):2484-93. PubMed ID: 12036356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted thiophene-anthranilamides as potent inhibitors of human factor Xa.
    Kochanny MJ; Adler M; Ewing J; Griedel BD; Ho E; Karanjawala R; Lee W; Lentz D; Liang AM; Morrissey MM; Phillips GB; Post J; Sacchi KL; Sakata ST; Subramanyam B; Vergona R; Walters J; White KA; Whitlow M; Ye B; Zhao Z; Shaw KJ
    Bioorg Med Chem; 2007 Mar; 15(5):2127-46. PubMed ID: 17227710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of human factor Xa complexed with potent inhibitors.
    Maignan S; Guilloteau JP; Pouzieux S; Choi-Sledeski YM; Becker MR; Klein SI; Ewing WR; Pauls HW; Spada AP; Mikol V
    J Med Chem; 2000 Aug; 43(17):3226-32. PubMed ID: 10966741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin.
    Stubbs MT; Huber R; Bode W
    FEBS Lett; 1995 Nov; 375(1-2):103-7. PubMed ID: 7498454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitors.
    Shi Y; O'Connor SP; Sitkoff D; Zhang J; Shi M; Bisaha SN; Wang Y; Li C; Ruan Z; Lawrence RM; Klei HE; Kish K; Liu EC; Seiler SM; Schweizer L; Steinbacher TE; Schumacher WA; Robl JA; Macor JE; Atwal KS; Stein PD
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7516-21. PubMed ID: 22041058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and quantitative structure-activity relationship of 3-amidinobenzyl-1H-indole-2-carboxamides as potent, nonchiral, and selective inhibitors of blood coagulation factor Xa.
    Matter H; Defossa E; Heinelt U; Blohm PM; Schneider D; Müller A; Herok S; Schreuder H; Liesum A; Brachvogel V; Lönze P; Walser A; Al-Obeidi F; Wildgoose P
    J Med Chem; 2002 Jun; 45(13):2749-69. PubMed ID: 12061878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design and synthesis of novel, potent bis-phenylamidine carboxylate factor Xa inhibitors.
    Maduskuie TP; McNamara KJ; Ru Y; Knabb RM; Stouten PF
    J Med Chem; 1998 Jan; 41(1):53-62. PubMed ID: 9438022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa.
    Verner E; Katz BA; Spencer JR; Allen D; Hataye J; Hruzewicz W; Hui HC; Kolesnikov A; Li Y; Luong C; Martelli A; Radika K; Rai R; She M; Shrader W; Sprengeler PA; Trapp S; Wang J; Young WB; Mackman RL
    J Med Chem; 2001 Aug; 44(17):2753-71. PubMed ID: 11495587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-phenylglycinol-derived non-covalent factor Xa inhibitors: effect of non-peptidic S4 linkage elements on affinity and anticoagulant activity.
    Klimkowski VJ; Watson BM; Wiley MR; Liebeschuetz J; Franciskovich JB; Marimuthu J; Bastian JA; Sall DJ; Smallwood JK; Chirgadze NY; Smith GF; Foster RS; Craft T; Sipes P; Chastain M; Sheehan SM
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5801-5. PubMed ID: 17881231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of the factor Xa inhibitor, ZK 807834 (CI-1031).
    Light DR; Guilford WJ
    Curr Top Med Chem; 2001 Jun; 1(2):121-36. PubMed ID: 11899248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed cation-pi mediated binding by factor Xa: a novel enzymatic mechanism for molecular recognition.
    Lin Z; Johnson ME
    FEBS Lett; 1995 Aug; 370(1-2):1-5. PubMed ID: 7649284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally active zwitterionic factor Xa inhibitors with long duration of action.
    Mochizuki A; Nagata T; Kanno H; Takano D; Kishida M; Suzuki M; Ohta T
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7337-43. PubMed ID: 22044620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket.
    Maignan S; Guilloteau JP; Choi-Sledeski YM; Becker MR; Ewing WR; Pauls HW; Spada AP; Mikol V
    J Med Chem; 2003 Feb; 46(5):685-90. PubMed ID: 12593649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.